- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 05.12. | Charles River Launches New Incubator Program for Biotech Startups | ||
| 05.12. | National Resilience Inc. Appoints New CEO | ||
| 05.12. | Charles River Supports Biotech Startups with New Incubator Program | ||
| 05.12. | Cambrex Partners with Lilly to Support Biotech Innovation | ||
| 05.12. | PDRadiopharma and NorthStar Partner on Cancer Therapeutics | ||
| 04.12. | Franklin Biolabs Appoints CEO | ||
| 04.12. | VIVEbiotech Secures Investment to Expand Lentiviral Vector Manufacturing | ||
| 04.12. | Takeda, Keros Enter Exclusive Elritercept Agreement | ||
| 04.12. | Amarna Therapeutics and NorthX Biologics Partner on Gene Therapy | ||
| 04.12. | Gilead, Tubulis Enter ADC Alliance Against Solid Tumor Target | ||
| 04.12. | CDMO Matica Bio Partners with Treovir for Pediatric Cancer Therapy | ||
| 04.12. | Samabriva Opens New Biomanufacturing Facility in Belgium | ||
| 03.12. | Coeptis Acquires AI-Powered Marketing Platform | ||
| 03.12. | COUR, Genentech Partner on Tolerogenic Therapy for Autoimmune Disease | ||
| 03.12. | KBI Biopharma & Alanis Therapeutics Partner to Advance Cancer Therapy | ||
| 03.12. | Hovione Expands in Europe and the US | ||
| 03.12. | COUR Pharma, Genentech Partner on Tolerogenic Therapy for Autoimmune Disease | ||
| 03.12. | Ipsen and Biomunex Join Forces to Develop First-in-Class Cancer Therapy | ||
| 03.12. | Symbiosis Pharmaceutical Services Expands Business Development Team | ||
| 03.12. | BioDuro-Sundia Appoints Alan Findlater as CCO | ||
| 03.12. | Lonza Launches Offering to Support Orally Delivered Biologic Therapies | ||
| 03.12. | Orbit Discovery & Evergreen Theragnostics Extend Research Collaboration | ||
| 03.12. | Romaco Appoints New Group CFO and Managing Director | ||
| 02.12. | Ampersand Capital Partners Acquires Nektar Therapeutics' PEG Reagent Manufacturing Business | ||
| 02.12. | TORL BioTherapeutics Appoints Aran Maree as Chief Medical Officer |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
